The objective of this study was to evaluate the level of appropriateness of prescribing to outpatients in selected healthcare facilities in Papua New Guinea (PNG), using health department guidelines as the benchmark.
Introduction
Prescribing medicines is a fundamental component of the care of patients and optimization of drug prescribing has become an important public health issue worldwide (Spinewine et al. 2007 ). Appropriate prescribing is embodied in the concept of rational drug use (RDU), as defined by the World Health Organization (WHO) and requires that patients receive prescribed medications appropriate to their clinical needs, in doses that meet their own requirements, for an adequate period of time and at an affordable cost to them and their community (WHO 2002a) . This topic has recently been reviewed by Holloway (2011) and many primary care based studies carried out over the period 1990 and 2006 have been summarized (WHO 2009) .
Inappropriate drug prescribing is a global healthcare problem (Plumridge 1984; Hogerzeil 1995; Kshirsagar et al. 1998; Fellows and Hughes 2000; Desta et al. 2002; Bhatnagar et al. 2003; Erah et al. 2003) . Factors that influence it include failure to prescribe in accordance with clinical guidelines, lack of knowledge and skills, unrestricted availability of medicines, overworked health personnel, out of date or lack of independent information, inappropriate self-medication often of prescription-only medicines, overuse of injections when oral formulations would be more appropriate and inappropriate use of antimicrobials and polypharmacy (Hogerzeil 1995; WHO 2002a; WCC 2006) . In addition, lack of medicines in stock in the dispensary may cause inappropriate prescribing (Hensen et al. 2011) . Mounting evidence supports the WHO contention that drugs are frequently not used to their full potential nor according to generally accepted criteria (WCC 2006; Walter et al. 2009 , WHO 2009 .
To assist in reducing the incidence of inappropriate drug prescribing, the following interventions are recommended; a mandated multi-disciplinary national body to co-ordinate medicine use policies, up to date clinical guidelines, professional supervision, audit and feedback, drug and therapeutics committees in districts and hospitals, continuing in-service medical education as a licensure requirement, essential medicines list based on current guidelines, availability of independent information on medicines, public education about medicines, sufficient government expenditure and processes to ensure availability of medicines, appropriate staff, appropriate and enforced regulation, avoidance of perverse financial incentives and problem-based pharmacotherapy training in undergraduate curricula (Hogerzeil 1995; Le-Grand et al. 1999; WHO 2002a; WCC 2006; Holloway 2011) .
Papua New Guinea
Papua New Guinea (PNG) is the largest nation in the Pacific and is classified as a low middle-income country with US$2084 GDP per capita (PPP) (WHO 2012) . The leading health problems continue to be communicable diseases, malaria, tuberculosis, diarrhoeal diseases and acute respiratory disease as major causes of morbidity and mortality (WHO 2012) . The PNG population (2007) was 6.4 million and 87% live in the rural areas (Barclay 2010; WHO 2012) . Life expectancy at birth (2007) was 60.7 years, and the total expenditure on health as a percentage of GDP (2005) (Economywatch 2012) .
PNG government support for RDU including appropriate prescribing
There is a scarcity of data available with regard to drug prescribing in PNG. In addition, access to essential medicines in PNG has been a continuing problem (DOH 2008b; McNee 2011) . In conformity with WHO initiatives regarding RDU, the PNG government approved its first ever National Drug Policy (NDP) in 1998 (DOH 1998) with the main objective to 'improve the health of the people by preventing and treating diseases through the availability and rational use of safe, effective, good quality and affordable drugs'. This policy provides for regulated importation and control over all drugs and medical supplies through registration and monitoring. In line with the NDP, the government, in September 1999, approved a Medicines and Cosmetics Act (DOH 1999) which, among its responsibilities, was to control the registration of all drugs used in PNG.
On the policy side, PNG has a National Health Plan 2001-10 (DOH 2000a,b) and a NDP (DOH 1998). On the regulation side, PNG has the Medicines and Cosmetic Act (DOH 1999) which included the establishment of the Pharmacy Board in 2000, and the current Medical and Dental Catalogue (DOH 2002) (Essential Drugs List). In addition, PNG has developed and distributed a range of Health Department guidelines relevant to a range of medical and surgical disciplines (refer Appendix 1).
The aim of this study was to evaluate the level of appropriateness of prescribing to outpatients in selected healthcare facilities in PNG with respect to current Health Department guidelines and to identify factors influencing prescribing quality in these settings.
Methodology
A prospective study was carried out at Losuia Health Centre (LHC), Alotau Provincial Hospital (APH) and Port Moresby General Hospital (PMGH) in PNG. This involved the recording of drug prescribing orders from written prescriptions, the diagnosis made by the prescriber obtained from the health book and where necessary by patient interviews. The health workers at the selected locations were informed of the study being carried out but not of its specific objectives. Those patients who gave consent to participate in the study were interviewed.
Losuia Health Centre
At LHC, the data collection took place from 2 to 14 April 2010. LHC serves a population of 23 000 people (MBA 2009) and acts as the referral centre for other sub-health centres in the Kiriwina-Goodenough District, which has a total population of 49 966 (2000 census) (NRI 2012) . LHC is headed by a Health Extension Officer (HEO) and staffed with nurses, community health workers (CHWs) and a dental therapist. Due to different languages spoken at Losuia, a CHW was assigned with the approval of the District Health Officer to assist the researcher in the data collection. A space with a table and two chairs next to the treatment room was provided for interviewing patients. The interviewing was undertaken by the CHW who spoke to the patients using their local dialect and the researcher recorded the outcome which took approximately <10 min.
Alotau Provincial Hospital
At APH, data collection took place from 2 to 14 July 2010. APH serves a population of 10 000 (NSO 2011) and acts as the referral hospital for Milne Bay Province, which has a population of 210 412 (NRI 2012; NSO 2011) . It is headed by a Chief Executive Officer. The interview of patients was carried out at the hospital pharmacy when patients came to collect their medicines. The interview was undertaken by the researcher with assistance from the pharmacist and pharmacy technician.
Port Moresby General Hospital
At the PMGH, data collection took place from 25 September to 6 October 2010. PMGH is headed by a Chief Executive Officer who oversees the running of the hospital. It serves a population of 254 158 (2000 census) (NSO 2011) and is the only national referral hospital in PNG for the whole population. Patient interviews were carried out at the hospital pharmacy when patients came to collect their medicines. The interview was undertaken by the researcher with assistance from the pharmacists and pharmacy technicians.
Data recording sheet
A data recording sheet was developed to collect data for each drug prescribed in the above health facilities. The data recording sheet collected the participant's prescription details and included patient's date of birth/age, weight, gender and date attending clinic, name of healthcare location, current diagnosis, current medicines prescribed (name, dose, frequency, duration, total number supplied), prescriber category, any injections given including total number supplied and additional current chronic medication still being taken by the patient. Data on current and relevant previous diagnoses and medications prescribed were recorded from a health booklet that was kept by each patient. A participant of 13 years or less was classified as a child.
For reasons of literacy, the data sheet was often completed by the researcher on questioning the patient/carer when they understood Pidgin-English. The Pidgin-English language is the language widely spoken in PNG and was used for oral communication throughout the study, while English was used as appropriate.
Administration of the protocols
The usual patient flow pattern at the health centre or hospital was as follows.
Normally, the patient would go to the cashier, pay the required outpatient/consultant entry fee of 20 toea (100 toea ¼ 1 Kina) at LHC, 10 Kina at APH and 2 Kina for outpatient and 10 Kina for consultation at PMGH, and proceed to the reception room to wait in a queue. Drugs were issued free to patients at LHC, 2 Kina per prescription at APH and 1 Kina per drug prescribed at PMGH (PNGK1.00 & US $0.48).
At LHC, when their turn came, patients were referred to see either a Nursing Officer (NO) or a CHW. The complicated cases would be referred to the HEO. If the case was serious, the patient would be referred to APH for further investigation. This hospital was not easily accessible as it involved 10-12 h of travel by boat or 30 min by air subject to availability of funds. Either service was available approximately once a week. At APH and PMGH, patients were referred to see either a NO, HEO or Medical Officer (MO). The complicated cases would be referred to the Specialist MO (SMO) or the Senior Specialist MO (SSMO). The diagnosis and prescribed medicines were written into the patient's health book, which they kept. The patient then proceeded to the pharmacy for the supply of medicines. After receiving their medicines, the patient was then asked to see the researcher.
Sample selection
The study sites were chosen for convenience. Consecutive outpatients seeking medicines during the 2-week study period at each site were screened and, if eligible, were invited to participate in the study. Subjects were deemed eligible provided they carried with them their health book and consented to participate in the study. However, eligible subjects were excluded if they were too ill to be interviewed, could not communicate or there was insufficient time for the consultation. In the case of children, their parent or guardian was interviewed.
Analysis of data
The appropriateness of prescribing was based upon compliance with relevant PNG guidelines as listed in Appendix 1. The criteria were based on the drug selection, drug dosage, drug frequency and drug duration as specified in the guidelines. Furthermore, 'overall appropriateness' was defined as appropriateness according to the previous four criteria plus the category of the prescription item complying with legislative restrictions on non-medical prescribers as defined in the Medical and Dental Catalogue (DOH 2002) . The diagnosis was that recorded by the prescriber in the patient's health book, which they had with them at the interview. Allocation of prescribing appropriateness was made by the researcher where no doubt existed and this was reviewed by two experts. Where doubt occurred regarding the allocation, a consensus decision was made by the researcher and the two independent experts. Data from the recording sheets were entered into an Excel Õ spreadsheet. Prescribed drugs were classified according to the ATC codes (WHO 2002b) . Tables were generated using the statistical software program SAS version 9.2 (SAS Institute Inc., Cary, USA, 2008). P-values to compare the profiles of subjects against various independent variables (including pharmacy location, gender and age group) were calculated using the chi-squared statistic unless otherwise specified. In all analyses, a P-value <0.05 was taken to indicate a statistically significant association.
Ethical issues
The research protocol was approved by the Milne Bay Province Medical Research Advisory Committee and the PMGH Executive Committee, including giving ethical clearance for it to be carried out in LHC, APH and PMGH. In addition, it was approved by the Human Research Ethics Committee of Curtin University.
Results
During the 2-week study period at each site, 356 subjects were enrolled at LHC, 318 at APH and 416 at PMGH. It was estimated that, of those invited to participate in the study, 90% agreed and completed the interview.
The basic demographic data of the patients are shown in Table 1 . The gender distribution was similar across the three sites. Approximately one-third of the subjects were children at the LHC (39.2%) and APH (33.3%) locations but a statistically significant smaller proportion (23.1%) of referrals to the national referral hospital were children.
More than one-half of the patients were prescribed one or two medications, with a range of 1-7. Less than 5% were prescribed more than four medications (Table 2 ). There was no difference (P ¼ 0.175) in the mean number of drugs prescribed per person at each location. Overall, 58.4% of patients were prescribed antibiotics at their consultation and a small proportion (9.3%) an injection ( Table 2 ). The most common disease diagnosed was malaria, accounting for more than one-fifth of the diagnoses (Table 3) . Soft tissue injuries and anaemia (iron products in pregnancy) were the next most frequent diagnoses. There was a low level of chronic diseases diagnosed. Amoxicillin products were commonly prescribed at each location (Table 4) , followed by paracetamol and its combinations, artemether/artesunates and other antimalarials were the next most frequently prescribed.
Most of the drug prescribing (Table 5) at LHC, which is a rural health centre, was undertaken by CHWs (31.5%) and NOs (55.1%). At APH and PMGH, which are urban hospitals, the drug prescribing was mostly undertaken by MOs and SMOs. There was a significant difference between prescriber categories across the three locations (P < 0.0001). When prescribers were grouped as non-medical and medical at each location, there was also a significant difference (P < 0.0001) between prescriber categories, dependent on location. It is notable that there were very few patients for whom prescribing was performed by Dental Officers, Dental Therapists or Resident Dental Officers (DO/DT/RDO). The frequency of inappropriate prescribing, based upon an application of the PNG guidelines at each location, is shown in Table 6 . At APH and PMGH, inappropriate drug selection was at levels of 31.0% and 27.7%, respectively. It is notable that medical doctors performed most of the drug prescribing in these centres. The prevalence of inappropriate drug prescribing across all locations, based on the guideline parameters of drug selection, drug dosage, drug frequency and drug duration combinations, was 33.3%, ranging from 30.4 to 37.9% for the different centres. One or more of the previous criteria being inappropriate rendered the item inappropriate in the 'summary row'. There were significant differences for each inappropriate category and the summary category assessed across the locations studied. Table 7 shows prescribing data separated for adults and children. Children received a higher number of inappropriate doses than adults and these were significantly different across the locations (P < 0.0001). The 'overall inappropriate' drug prescribing included the additional criterion of 'inappropriate item prescribed', based upon legislative restrictions on non-medical prescribers. This gives 'overall' inappropriate levels of 33.4% for adults and 39.9% for children. It was 53.8% for children at APH.
As shown in Table 8 , statistically significant differences were observed in the level of inappropriate prescribing by prescriber category on drug selection (P < 0.0001), drug dosage (P < 0.0001), drug frequency (P ¼ 0.0373) and drug duration (P < 0.0001). There was a significant difference (P ¼ 0.00014) in the 'inappropriateness' of drug prescribing with respect to prescriber category. HEOs showed the highest levels of inappropriate drug prescribing with CHWs and MOs showing moderate levels (Table 8) .
Discussion
This is the first study that has systematically evaluated the prevalence of inappropriate drug prescribing by medical and non-medical staff in different healthcare settings in PNG. A sample in excess of 1000 patients was evaluated over three sites ranging from a rural health centre to the main referral hospital in the country. It is notable that the number of children in the samples was <40%, which is lower than expected based on the population data. However, an individual aged 13 or less is classified as a child within the PNG health system. Malaria was the most common disease managed and is very demanding on the health resources in PNG. The average of 2.3 drugs prescribed per patient was higher than the value of 1.6-1.8 reported by Isah et al. (1997) , but considered acceptable for this population. This study includes rural and remote populations in PNG and a broad range of trained staff to manage their dispersed population. A hierarchical health system, including a referral system, is active in the country: however, in remote villages, it may be difficult for patients to be transported to a larger referral clinic.
This study has found high levels of inappropriate drug prescribing in each setting evaluated. It is notable that, at the rural health centre, 32.7% of prescriptions were inappropriate, mainly arising from inappropriate drug dosages. This centre had the highest number of children, requiring more dosage calculations than at the other centres. At the provincial and referral hospitals, drug selection was the main contributor where MOs carried out the majority of the prescribing. All prescribing is carried out by non-medical staff at health centres, whereas a combination of medical and non-medical staff prescribed at hospitals. It is notable that non-medical prescribers at LHC had lower levels of inappropriate drug selection but higher levels of drug dosage errors. This might indicate that they follow guidelines for selection, but dosage calculations may be a difficulty for them. Data shown in Table 8 indicated that CHWs and NOs showed very low levels of selection errors but high levels of calculation errors. The reverse situation occurred with MOs. The small amount of prescribing recorded for the dental categories showed correct prescribing for all medications.
Prescribing by a range of medical and non-medical personnel is permitted in PNG owing to the lack of availability of MOs in rural areas (Joshua and Sunderland 2008; Barclay 2010) . There is a limited formulary permitted for non-medical prescribers, compared with medical prescribers, according to the Medical and Dental Catalogue (DOH 2002) , which is the essential drugs list for PNG. The study found 54.1% of prescribing was from medically qualified staff (Table 5) with the remainder by a range of non-medical prescribers. Of this latter group, HEOs have received more comprehensive training in diagnosis and prescribing than CHWs and NOs who, however, carried out most of the non-medical prescribing reported in this study.
Inappropriate prescribing by HEOs was 41.2% and by MOs, was 34.8% and CHWs made the highest percentage of dosage errors. It is notable that overall inappropriate prescribing was higher for children (39.9%), compared with adults (33.4%).
It is possible that, considering data shown in Table 8 , the limited knowledge and skills of CHWs on drug matters may have contributed to the inappropriate prescribing (19.5%) on drug dosages. Studies in Nigeria indicated that a prescriber's The P-values are across locations. b Relates to the occurrence of at least one of the four prescribing criteria deemed inappropriate for a prescribed drug for it to be classified as inappropriate. level of training or lack of training is one factor that would influence drug prescribing in health facilities (Erah et al. 2003) . The underlying factors leading to inappropriate drug prescribing are complex. They include societal and health system factors as well as education, training, continuing professional education and access to data (Hogerzeil 1995; Le-Grand et al. 1999; WHO 2002a WHO ,c, 2004 Holloway 2011) . The guidelines used for this study were available to prescribers at each setting. Long queues of patients were a common occurrence in all settings, increasing the stress on staff to manage these patients. The three locations evaluated in this study were all publicly funded institutions. Patients paid only a nominal fee, which should not be a major barrier to access services. In LHC, isolation and a lack of doctors are major factors and ill patients may have significant transport difficulties to attend a provincial hospital. It was noteworthy that, of the 356 patients evaluated in this study at LHC, only 11.5% were diagnosed or prescribed for chronic diseases such as hypertension and Types 1 or 2 diabetes.
The interventions to address the inappropriate levels of prescribing need to be carefully considered prior to implementation. These would include reviews of the prescribing guidelines and their alignment with the drug (medical and dental) catalogue (DOH 2002) . For example, methyldopa is currently stated in the guidelines as the drug of choice for hypertension, while enalapril is in the essential drugs list. Similarly, only lifestyle changes are recommended for Type 2 diabetes, while metformin is in the essential drugs list. As prescribers at health centres are all non-medical, and often these centres are isolated from other services, the range of drugs that can be prescribed by non-medical prescribers should be reviewed. Because of their high prevalence, such a review may allow broader access and updated treatment of hypertension and Type 2 diabetes in particular. The review could include a separation of the limitations into specific groups of non-medical prescribers.
Limitations of the study
This preliminary study has investigated only three healthcare facilities at different levels in the health system in PNG. It would not be appropriate to generalize these data across PNG with the exception of PMGH, which is the only major referral hospital in the country. Data were collected over a 2-week period and no reason was identified that this was different from any other period: however, there is a possibility this could occur. Drug supplies should arrive every 2 months and data were collected approximately mid-way between delivery dates. It is likely that drug shortages could increase towards the end of the delivery cycle, perhaps influencing prescribing. The P-values are across prescriber categories.
